Danaher Corporation (ETR:DAP)
Germany flag Germany · Delayed Price · Currency is EUR
188.48
-2.12 (-1.11%)
Mar 31, 2025, 2:44 PM CET

Danaher Company Description

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.

Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands.

The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians’ offices, reference laboratories, and other critical care settings.

The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.

Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Danaher Corporation
Danaher logo
Country United States
Founded 1969
Industry Diagnostics & Research
Sector Healthcare
Employees 63,000
CEO Rainer Blair

Contact Details

Address:
2200 Pennsylvania Avenue N.W.
Washington, Delaware 20037-1701
United States
Phone 202 828 0850
Website danaher.com

Stock Details

Ticker Symbol DAP
Exchange Deutsche Börse Xetra
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US2358511028
SIC Code 3826

Key Executives

Name Position
Rainer M. Blair President, Chief Executive Officer and Director
Steven M. Rales Co-Founder and Chairman
Mitchell P. Rales Co-Founder and Director
Matthew R. McGrew Chief Financial Officer and Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Senior Vice President and Chief Science Officer
Georgeann F. Couchara Senior Vice President of Human Resources
Christopher M. Bouda Vice President and Chief Accounting Officer
John Bedford Vice President of Investor Relations
Brian W. Ellis J.D. Senior Vice President, General Counsel and Chief Compliance Officer
Daniel A. Raskas J.D. Senior Vice President of Corporate Development